Get started
Author

Fiona M. Goeckel

Observed institution: Chestnut Hill College
ORCID: 0009-0005-3726-0409
Observed ORCID: 0009-0005-3726-0409
OpenAlex ID: A5144060952
Supplementary Figure S7 from Combination AURKA and WEE1 Inhibition Exhibits Efficacy in EGFR or Pan-ERBB Inhibitor–Resistant Head and Neck Squamous Cell Carcinoma
2026 · Flaviane N. Silva, Jong Woo Lee, et al.
Figure 4 from Combination AURKA and WEE1 Inhibition Exhibits Efficacy in EGFR or Pan-ERBB Inhibitor–Resistant Head and Neck Squamous Cell Carcinoma
2026 · Flaviane N. Silva, Jong Woo Lee, et al.
Supplementary Figure S6 from Combination AURKA and WEE1 Inhibition Exhibits Efficacy in EGFR or Pan-ERBB Inhibitor–Resistant Head and Neck Squamous Cell Carcinoma
2026 · Flaviane N. Silva, Jong Woo Lee, et al.
Supplementary Figure S2 from Combination AURKA and WEE1 Inhibition Exhibits Efficacy in EGFR or Pan-ERBB Inhibitor–Resistant Head and Neck Squamous Cell Carcinoma
2026 · Flaviane N. Silva, Jong Woo Lee, et al.
Supplementary Figure S4 from Combination AURKA and WEE1 Inhibition Exhibits Efficacy in EGFR or Pan-ERBB Inhibitor–Resistant Head and Neck Squamous Cell Carcinoma
2026 · Flaviane N. Silva, Jong Woo Lee, et al.
Figure 1 from Combination AURKA and WEE1 Inhibition Exhibits Efficacy in EGFR or Pan-ERBB Inhibitor–Resistant Head and Neck Squamous Cell Carcinoma
2026 · Flaviane N. Silva, Jong Woo Lee, et al.
Figure 6 from Combination AURKA and WEE1 Inhibition Exhibits Efficacy in EGFR or Pan-ERBB Inhibitor–Resistant Head and Neck Squamous Cell Carcinoma
2026 · Flaviane N. Silva, Jong Woo Lee, et al.
Supplementary Figure S5 from Combination AURKA and WEE1 Inhibition Exhibits Efficacy in EGFR or Pan-ERBB Inhibitor–Resistant Head and Neck Squamous Cell Carcinoma
2026 · Flaviane N. Silva, Jong Woo Lee, et al.
Data from Combination AURKA and WEE1 Inhibition Exhibits Efficacy in EGFR or Pan-ERBB Inhibitor–Resistant Head and Neck Squamous Cell Carcinoma
2026 · Flaviane N. Silva, Jong Woo Lee, et al.
Figure 3 from Combination AURKA and WEE1 Inhibition Exhibits Efficacy in EGFR or Pan-ERBB Inhibitor–Resistant Head and Neck Squamous Cell Carcinoma
2026 · Flaviane N. Silva, Jong Woo Lee, et al.
Supplementary Figure S3 from Combination AURKA and WEE1 Inhibition Exhibits Efficacy in EGFR or Pan-ERBB Inhibitor–Resistant Head and Neck Squamous Cell Carcinoma
2026 · Flaviane N. Silva, Jong Woo Lee, et al.
Figure 5 from Combination AURKA and WEE1 Inhibition Exhibits Efficacy in EGFR or Pan-ERBB Inhibitor–Resistant Head and Neck Squamous Cell Carcinoma
2026 · Flaviane N. Silva, Jong Woo Lee, et al.
Figure 2 from Combination AURKA and WEE1 Inhibition Exhibits Efficacy in EGFR or Pan-ERBB Inhibitor–Resistant Head and Neck Squamous Cell Carcinoma
2026 · Flaviane N. Silva, Jong Woo Lee, et al.
Supplementary Table S1 from Combination AURKA and WEE1 Inhibition Exhibits Efficacy in EGFR or Pan-ERBB Inhibitor–Resistant Head and Neck Squamous Cell Carcinoma
2026 · Flaviane N. Silva, Jong Woo Lee, et al.
Supplementary Table S2 from Combination AURKA and WEE1 Inhibition Exhibits Efficacy in EGFR or Pan-ERBB Inhibitor–Resistant Head and Neck Squamous Cell Carcinoma
2026 · Flaviane N. Silva, Jong Woo Lee, et al.
Supplementary Figure S8 from Combination AURKA and WEE1 Inhibition Exhibits Efficacy in EGFR or Pan-ERBB Inhibitor–Resistant Head and Neck Squamous Cell Carcinoma
2026 · Flaviane N. Silva, Jong Woo Lee, et al.
Supplementary Figure S1 from Combination AURKA and WEE1 Inhibition Exhibits Efficacy in EGFR or Pan-ERBB Inhibitor–Resistant Head and Neck Squamous Cell Carcinoma
2026 · Flaviane N. Silva, Jong Woo Lee, et al.
Combination AURKA and WEE1 Inhibition Exhibits Efficacy in EGFR or Pan-ERBB Inhibitor–Resistant Head and Neck Squamous Cell Carcinoma
2026 · Flaviane N. Silva, Jong Woo Lee, et al. · Cancer Research Communications
Works count: 18
Citation count:
H-index:
I10-index:
Year
Topic
Type